Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept plus UVB in moderate to severe psoriasis vulgaris
2008-000106-37Phase 4Active
- Sponsor
- Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum
- Start
- May 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of etanercept in plaque psoriasis (2 cohorts), sponsored by Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum. Primary endpoint: Acute impact of etanercept on UVB-induced effects (Part 1). Started May 2008; status: active.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2008-000106-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000106-37.